Other languages Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.736 ^USD	-0.25%		-19.27%	-3.30%

Mar. 15	North American Morning Briefing : Inflation -2-	DJ
Mar. 14	Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala, JD to Its Board of Directors	Feb. 20
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala to the Board of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee	Feb. 16
Eterna Therapeutics Inc. Announces Management Changes	Jan. 19
Eterna Therapeutics Inc Announces Chief Executive Officer Changes, Effective January 1, 2024	Dec. 20
Eterna Therapeutics Inc Appoints Sanjeev Luther as President and Member of the Board of Directors, Effective January 1, 2024	Dec. 20
Eterna Therapeutics Inc. Appoints James Bristol as Chairman of the Board	Dec. 20
Eterna Therapeutics Inc. Enter into an Exclusive Amended and Restated License Agreement with Factor Bioscience Limited	Nov. 16
Eterna Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Eterna Therapeutics Inc. Appoints James Bristol to Its Board of Directors	Nov. 01
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer	23-10-30
Gregory Fiore Resigns from Eterna Therapeutics Inc.'s Board of Directors	23-10-05
Lineage Cell Therapeutics, Inc. Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership with Eterna Therapeutics	23-09-06
Eterna Therapeutics Inc. Appoints Ms. Dorothy J. Clarke as Director, Effective on August 28, 2023	23-08-31
Eterna Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
Eterna Therapeutics Inc. Announces Management Changes	23-08-10
Eterna Therapeutics Inc. Announces Board Changes	23-07-11
Eterna Therapeutics Inc. Appoints Megan Yung as Chief Strategy Officer, General Counsel	23-05-24
Eterna Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Eterna Therapeutics Inc. Appoints Gregory Fiore to Chair the Committee on Board Focusing on Business Development	23-05-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Other languages

Filters